Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

科研成果: 期刊稿件 › 文章 › 同行评审

!!!ASJC Scopus Subject Areas

此成果有助于实现下列可持续发展目标：

@article{9b4bd67a00064bf1b0c563b15379bafd,

title = "Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2019",

month = apr,

doi = "10.1016/j.eclinm.2019.04.007",

language = "English",

volume = "10",

pages = "32--41",

journal = "EClinicalMedicine",

issn = "2589-5370",

publisher = "Lancet Publishing Group",

}

TY - JOUR

T1 - Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85064928023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064928023&partnerID=8YFLogxK

U2 - 10.1016/j.eclinm.2019.04.007

DO - 10.1016/j.eclinm.2019.04.007

M3 - Article

AN - SCOPUS:85064928023

SN - 2589-5370

VL - 10

SP - 32

EP - 41

JO - EClinicalMedicine

JF - EClinicalMedicine

ER -